Aaron M. Allen

5.0k total citations · 1 hit paper
81 papers, 3.5k citations indexed

About

Aaron M. Allen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Aaron M. Allen has authored 81 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Aaron M. Allen's work include Advanced Radiotherapy Techniques (24 papers), Lung Cancer Diagnosis and Treatment (20 papers) and Head and Neck Cancer Studies (18 papers). Aaron M. Allen is often cited by papers focused on Advanced Radiotherapy Techniques (24 papers), Lung Cancer Diagnosis and Treatment (20 papers) and Head and Neck Cancer Studies (18 papers). Aaron M. Allen collaborates with scholars based in United States, Israel and Canada. Aaron M. Allen's co-authors include Lori J. Pierce, Giovanna Gagliardi, Vitali Moiseenko, Candace R. Correa, Louis S. Constine, Yaacov Richard Lawrence, Laurence E. Court, Hale Başak Çağlar, Roy B. Tishler and Raphael Bueno and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Aaron M. Allen

77 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiation Dose–Volume Effects in the Heart

2010 973 citations Aaron M. Allen et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by Aaron M. Allen

Since Specialization

Citations

This map shows the geographic impact of Aaron M. Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron M. Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron M. Allen more than expected).

Fields of papers citing papers by Aaron M. Allen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron M. Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron M. Allen. The network helps show where Aaron M. Allen may publish in the future.

Co-authorship network of co-authors of Aaron M. Allen

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron M. Allen. A scholar is included among the top collaborators of Aaron M. Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron M. Allen. Aaron M. Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non‐small cell lung cancer: A large real‐world cohort and review of the literature 2023 ·Thoracic Cancer ·(unknown), Roi Tschernichovsky, (unknown), Daniel A. Goldstein, (unknown), Elizabeth Dudnik, Ofer Rotem, Nir Peled, Aaron M. Allen, (unknown), Yael Goldberg, Alona Zer	3
2	The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer 2021 ·Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Ofer Rotem, (unknown), Aaron M. Allen, Elizabeth Dudnik, Daniel A. Goldstein, Alona Zer	20
3	Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non‐small‐cell lung cancer 2020 ·Asia-Pacific Journal of Clinical Oncology ·(unknown), Liran Domachevsky, David Groshar, Elizabeth Dudnik, Ofer Rotem, Aaron M. Allen, Nir Peled, (unknown), (unknown), Tzippy Shochat, Hanna Bernstine, Alona Zer	4
4	Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant 2020 ·Radiology and Oncology ·Assaf Moore, Mordechai R. Kramer, Dror Rosengarten, Osnat Shtraichman, Alona Zer, Elizabeth Dudnik, (unknown), Aaron M. Allen	1
5	Lung Cancer in Israel 2020 ·Journal of Thoracic Oncology ·(unknown), Yael Refaely, (unknown), Dorith Shaham, Elizabeth Dudnik, (unknown), Aaron M. Allen, Nir Peled	2
6	Efficacy and Safety of <b><i>ALK</i></b> Tyrosine Kinase Inhibitors in Elderly Patients with Advanced <b><i>ALK</i></b>-Positive Non-Small Cell Lung Cancer: Findings from the Real-Life Cohort 2019 ·Oncology Research and Treatment ·(unknown), Nir Peled, (unknown), Moshe Mishaeli, Tzippy Shochat, Alona Zer, Ofer Rotem, Aaron M. Allen, Jair Bar, Elizabeth Dudnik, (unknown)	8
7	Endobronchial brachytherapy—A novel approach for the management of airway amyloidosis 2018 ·Brachytherapy ·Assaf Moore, Mordechai R. Kramer, (unknown), Osnat Shtraichman, Aaron M. Allen	5
8	Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma 2017 ·Radiation Oncology ·Assaf Moore, Michal Cohen‐Naftaly, Anna Tobar, Yulia Kundel, Ofer Benjaminov, Marius Braun, Assaf Issachar, Eytan Mor, Michal Sarfaty, (unknown), (unknown), Noa Gordon, Salomon M. Stemmer, Aaron M. Allen	55
9	The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer 2015 ·European Radiology ·Alona Zer, Liran Domachevsky, (unknown), (unknown), Dov Flex, Aaron M. Allen, Salomon M. Stemmer, David Groshar, Hanna Bernstine	37
10	Clinical Utility of 4D FDG-PET/CT Scans in Radiation Treatment Planning 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Michalis Aristophanous, Ross Berbeco, Joseph H. Killoran, Jeffrey T. Yap, David J. Sher, Aaron M. Allen, Elysia Larson, Aileen B. Chen	73
11	Radiation Dose–Volume Effects in the Larynx and Pharynx 2010 ·International Journal of Radiation OncologyBiologyPhysics ·T. Rancati, Marco Schwarz, Aaron M. Allen, Felix Y. Feng, Aron Popovtzer, Bharat B. Mittal, Avraham Eisbruch	165
12	Evaluation of the dose calculation accuracy in intensity‐modulated radiation therapy for mesothelioma, focusing on low doses to the contralateral lung 2009 ·Journal of Applied Clinical Medical Physics ·Laurence E. Court, (unknown), Deborah Schofield, M. Czerminska, Aaron M. Allen	10
13	Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck 2009 ·Annals of Oncology ·Lori J. Wirth, Aaron M. Allen, Marshall R. Posner, Robert I. Haddad, Y. Li, J. Clark, Paul M. Busse, Annie W. Chan, Laura A. Goguen, Charles M. Norris, Donald J. Annino, Roy B. Tishler	47
14	Evaluation of the interplay effect when using RapidArc to treat targets moving in the craniocaudal or right‐left direction 2009 ·Medical Physics ·Laurence E. Court, (unknown), Ross Berbeco, (unknown), Brian Winey, Deborah Schofield, Dan Ionascu, Aaron M. Allen, Richard A. Popple, (unknown)	63
15	Experimental evaluation of the accuracy of skin dose calculation for a commercial treatment planning system 2008 ·Journal of Applied Clinical Medical Physics ·Laurence E. Court, Roy B. Tishler, Aaron M. Allen, Hong Xiang, Mike Makrigiorgos, Lee M. Chin	59
16	Monitoring of tumor response to therapy by 18F-ML-10, a novel small-molecule PET tracer for apoptosis: From preclinical to clinical studies 2008 ·Clinical Cancer Research ·Anat Shirvan, Hagit Grimberg, Galit Levin, Avi Cohen, Ayelet Reshef, (unknown), Aaron M. Allen, Eyal Fenig, Adam Steinmetz, David Groshar, (unknown), Yulia Kundel, Eyal Mishani, Ilan Ziv	1
17	Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Hale Başak Çağlar, Roy B. Tishler, Megan Othus, Elaine Burke, Li Yi, Laura A. Goguen, Lori J. Wirth, Robert I. Haddad, (unknown), Laurence E. Court, (unknown), Marshall R. Posner, Aaron M. Allen	179
18	Influence of Radiotherapy Technique and Dose on Patterns of Failure for Mesothelioma Patients After Extrapleural Pneumonectomy 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Aaron M. Allen, Robert B. Den, Julia S. Wong, David Zurakowski, (unknown), Pasi A. Jänne, Lambros Zellos, Raphael Bueno, David J. Sugarbaker, Elizabeth H. Baldini	35
19	Restricted Field IMRT Dramatically Enhances IMRT Planning for Mesothelioma 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Aaron M. Allen, Deborah Schofield, Fred Hacker, Laurence E. Court, M. Czerminska	37
20	Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Aaron M. Allen, Mark M. Zalupski, John M. Robertson, Frederic E. Eckhäuser, (unknown), Diane Brown, (unknown), Daniel P. Normolle, Theodore S. Lawrence, Cornelius J. McGinn	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact